Predict your next investment

Other

See what CB Insights has to offer

Investments

2

Funds

1

About UNO Investment

UNO Investment (우노인베스트먼트) is based in South Korea.

UNO Investment Headquarter Location

South Korea

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

UNO Investment Investments

2 Investments

UNO Investment has made 2 investments. Their latest investment was in ImmuneMed as part of their Series C on April 4, 2019.

CBI Logo

UNO Investment Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/5/2019

Series C

ImmuneMed

$14.19M

Yes

2

4/1/2019

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/5/2019

4/1/2019

Round

Series C

Series C

Company

ImmuneMed

Subscribe to see more

Amount

$14.19M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

2

10

UNO Investment Fund History

1 Fund History

UNO Investment has 1 fund, including UNOi Blockbuster Discovery Venture Fund 1.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/16/2018

UNOi Blockbuster Discovery Venture Fund 1

Multi-Stage Venture Capital

Closed

$14.19M

1

Closing Date

4/16/2018

Fund

UNOi Blockbuster Discovery Venture Fund 1

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

$14.19M

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.